Medtronic Pulls HeartWare Devices After Higher Risk Of Death Compared To Abbott’s HeartMate 3
Executive Summary
The company had issued two recalls in the past few months for the device due to recorded deaths and adverse events, but after further analyses has decided to pull it off the market altogether.
You may also be interested in...
Medtronic Announces Backup Software For Failed HVAD Pumps
After a flurry of recalls related to its HeartWare Ventricular Assist Device System, Medtronic says a backup controller with modified software is now available in the event of a pump failure for hospitals using the system.
Patients With HVAD System At Risk, Warns FDA
The US Food and Drug Administration is advising health care providers that patients with the Medtronic Heartware Ventricular Assist Device (HVAD) System are at risk from potential device malfunction.
House Chair Wants Answers On The FDA’s Handling Of Dangerous Device
The Chairman of the US House Subcommittee on Economic and Consumer Policy is pressing the FDA on why it allowed what he says is a dangerous medical device to stay on the market for so long.